The World's Health Care Crisis: From the Laboratory Bench to the Patient's Bedside

Available
Product Details
Price
$126.00
Publisher
Elsevier
Publish Date
Pages
296
Dimensions
6.0 X 9.0 X 0.69 inches | 1.24 pounds
Language
English
Type
Hardcover
EAN/UPC
9780123918758

Earn by promoting books

Earn money by sharing your favorite books through our Affiliate program.

Become an affiliate
About the Author
Ibis Sánchez-Serrano is a world-leading expert on global healthcare, pharmaceutical innovation, and translational science policy. He is a member of the Editorial Board of the journal Gender & the Genome and has written two books, The World's Health Care Crisis: From the Laboratory Bench to the Patient's Bedside (Elsevier, 2011) and The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care (Elsevier, 2019). Mr. Sánchez-Serrano has built a reputation amongst important international government bodies as an expert on the world's healthcare crisis and the relevant solutions. He's a frequent speaker on global health care and pharmaceutical development and received international recognitions for his work on global health care, including a "Fulbright Recognition Award" and media coverage including CNN, C-SPAN, UNIVISION, EFE Agency, Deutsche Presse Agentur. His research interests include Health Care, Pharmaceuticals, Biotechnology, Public Health, Academia-Industry Relationship, Drug Discovery and Development, Organization and Management of R&D.
Reviews

"This book is an excellent summary of the health-care crisis facing the world today, comparing health care in wealthy, industrial countries to that in poor, underdeveloped countries. Sánchez-Serrano, a Panamian health-care adviser/consultant, covers the history of health care, including pharmaceutically driven treatments; challenges with new drug discoveries; unmet medical needs; and profits. The author also emphasizes the high cost of research and development for new drugs. He explores the issues related to government-supplemented research and summarizes the interaction of government-sponsored basic research, academic (pure) science research, venture capital investors, and industry.... The author provides many specific examples of successes and failures of past/present systems and discusses the evolution of pharmaceutical company philosophies in the past 150 years and future challenges. This book is fact based and nonpartisan. The only areas not explored are the modern diagnostics industry, the phenomenal advances in medical devices, and the cost of modern physician care (and the cost of physicians' education). Summing Up: Highly Recommended" --Choice